![]() |
市场调查报告书
商品编码
1828160
2025年全球脉动式血氧监测仪系统市场报告Pulse Oximeter Global Market Report 2025 |
||||||
近年来,脉动式血氧监测仪系统市场规模稳定成长,从2024年的26.4亿美元增加到2025年的27.3亿美元,复合年增长率为3.6%。预测期内的增长可归因于老年人口的增长、呼吸系统疾病盛行率的上升、医院和医疗基础设施的发展、意识提升以及全球疫情的影响。
预计2029年,脉动式血氧监测仪系统市场规模将成长至34.8亿美元,复合年增长率为6.2%。预测期内的成长可归因于与穿戴式装置的整合、全球健康危机防范、政府医疗保健计画、健康和保健监测以及全球健康危机防范。预测期内的主要趋势包括远端医疗整合、技术进步、对居家医疗的重视、智慧功能和连接性以及针对慢性病的远端患者监护。
脉动式血氧监测仪系统是一种非侵入式测量设备,可快速测量个人的功能性血氧饱和度 (SpO2),并有助于及早发现低氧血症。脉动式血氧监测仪系统的主要功能是无需针头或采血即可快速评估人体的血氧饱和度。
脉动式血氧监测仪系统种类繁多,可满足各种特定需求,包括指尖血氧仪、手持式血氧仪、腕戴式血氧仪、桌上型血氧仪和床边血氧仪。指尖血氧仪的设计尤其方便佩戴在患者指尖,并融合了连网技术和传统技术。这些设备经过编程,可同时适用于成人和儿童患者。目标终端使用者包括医院、诊所、门诊手术中心和家庭医疗保健机构。
2025年美国关税大幅上调及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战进一步加剧了形势,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快研发更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供脉动式血氧监测仪系统市场的统计数据,包括全球市场规模、各地区市场份额、竞争对手的脉动式血氧监测仪系统份额、脉动式血氧监测仪系统脉动式血氧监测仪系统。本脉动式血氧监测仪系统脉动式血氧监测仪系统研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的全面观点。
未来五年的预测成长率为6.2%,较我们先前对该市场的预测略有下降0.3%。下降的主要原因是美国与其他国家之间关税的影响。这将直接影响美国,导致光电二极体感测器和多波长发光二极体二极体(LED) 阵列的成本上升,这些产品主要从中国大陆和台湾进口,这可能会影响病患监测设备的供应。此外,由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,影响范围也将更加广泛。
呼吸系统疾病盛行率的上升预计将推动未来脉动式血氧监测仪系统市场的成长。呼吸系统疾病会影响呼吸道和肺部,进而影响人类呼吸。这种增长主要是由于空气污染加剧、粉尘暴露、人口老化和吸烟习惯等因素造成的。脉动式血氧监测仪系统的价值在于它们可以在症状变得明显之前检测到血氧饱和度水平的变化。例如,2023 年 12 月,美国政府机构国家生物技术资讯中心报告称,预计 COPD 患者数量将增加 1.12 亿,到 2050 年将达到总合亿,占受目标人口的 9.5%。因此,呼吸系统疾病盛行率的上升正在推动对脉动式血氧监测仪系统的需求。
远端医疗和远端医疗的扩展预计将在未来推动脉动式血氧监测仪系统市场的成长。远端医疗包括使用通讯技术远端提供各种医疗服务和讯息,而远端医疗则具体指远距临床咨询和医疗保健服务。脉动式血氧监测仪系统在评估远端位置的氧气水平方面发挥关键作用,这对于慢性病患者的家庭医疗保健尤其重要。脉动式血氧监测仪系统与穿戴式装置和智慧型手机集成,可增强其在远端医疗中的效用,并实现无缝资料共用。这种整合减少了去医院就诊的需要,因为患者可以在家中使用脉动式血氧监测仪系统并传输即时数据进行远端评估。例如,美国政府机构疾病管制与预防中心在 2024 年 6 月报告称,2022 年有 30.1% 的成年人在过去一年中使用过远端医疗。因此,远端医疗和远端医疗的扩展正在推动脉动式血氧监测仪系统市场的成长。
脉动式血氧监测仪系统市场的主要企业专注于开发技术先进的解决方案,例如蜂窝连接脉动式血氧监测仪系统,以改善患者监测和数据收集。蜂窝连接脉动式血氧监测仪系统具有蜂窝连接功能,允许它们透过蜂巢式网路(例如 4G 和 5G)将数据无线传输到医疗保健提供者和云端基础的健康平台。例如,2024 年 8 月,美国远端监控平台开发商 Prevounce Health LLC 推出了 Pylo OX1-LTE,这是一款专为远端患者监护(RPM) 设计的蜂窝连接脉动式血氧监测仪系统。该设备针对患有慢性阻塞性肺病和气喘等慢性呼吸系统疾病的患者以及受 COVID-19 影响的患者,提供可靠的蜂窝连接、准确的 SpO2 和脉搏率读数,以及带有明亮 OLED 屏幕的用户友好型设计。它与 Prevounce 的远端护理管理平台无缝集成,并可透过 Pylo Cloud API 连接到第三方健康软体。
脉动式血氧监测仪系统市场的主要企业正在积极投资最尖端科技,例如脉搏血氧计(SpO2) 感测器技术,以增强其竞争地位。脉搏血氧计(SpO2) 感测器技术采用专门的感测器来测量血氧饱和度水平,通常称为 SpO2。2022 年 11 月,美国病患监测解决方案公司 BioIntelliSense Inc. 推出了创新的脉搏血氧计(SpO2) 感测器技术,该技术可解决与皮肤色素沉着和运动监测相关的挑战。这种取得专利的感测器晶片组和整合处理技术可确保在不同肤色和运动过程中达到临床级的准确度。这项突破性技术旨在透过克服过去在活动和较深肤色期间的准确度问题来促进医疗保健公平。其设计结合了独特的白光发送器和频谱感测器,超越了传统架构,可提供临床精确的 SpO2 测量值。
2022年1月,美国输液治疗和重症加护专家ICU Medical完成了对史密斯医疗的收购,收购金额未揭露。这项策略性措施扩展了史密斯医疗的产品线,包括输液帮浦、导管和一系列血管通路设备。史密斯医疗总部位于美国,专注于脉动式血氧监测仪系统等创新医疗产品,此次收购将为ICU Medical的产品组合增添宝贵的多样性。
脉动式血氧监测仪系统市场的主要企业包括美敦力公司、通用电气医疗集团、Masimo 公司、Nonin Medical 公司、日本光电公司、荷兰皇家飞利浦公司、飞利浦医疗保健公司、Contec Medical Systems 公司、欧姆龙公司、Carefusion 公司、CAS Medical Systems 公司、Opto Circuits India 公司、欧姆龙公司、Carefusion 公司、CAS Medical Systems 公司、Opto Circuits India.公司、Beurer GmbH 公司、Dragerwerk AG &Co.KGaA 公司、ICU Medical 公司、Smiths Medical 公司、迈瑞医疗国际有限公司、Criticare Systems 公司、BPL Medical Technologies 公司、ChoiceMMed America 公司、北京 Choice 电子技术有限公司、Creative Medical 公司、Edan Instruments 公司、Heal Holdings、Peal Holdings 公司、Edan Force Instruments 公司。
2024 年,北美是脉动式血氧监测仪系统市场最大的地区。脉动式血氧监测仪系统市场报告涵盖以下地区:亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
脉动式血氧监测仪系统市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。
脉动式血氧监测仪系统市场涵盖指尖脉动式血氧监测仪系统和血氧饱和度监测仪的销售。该市场的价值指的是“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
A pulse oximeter serves as a non-invasive measurement device that promptly gauges an individual's functional oxygen saturation (SpO2), facilitating early detection of hypoxemia. The primary functionality of a pulse oximeter is to swiftly assess oxygen saturation levels in the human body without the necessity for needles or blood samples.
Diverse categories of pulse oximeters cater to specific needs, including fingertip oximeters, handheld oximeters, wrist-worn oximeters, and table-top and bedside oximeters. Fingertip oximeters, specifically, are designed for convenient attachment to a patient's fingertip, incorporating a blend of connected and conventional technologies. These devices are programmed to cater to both adult and pediatric populations. Targeted end-users encompass hospitals and clinics, ambulatory surgical centers, and home healthcare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The pulse oximeters market research report is one of a series of new reports from The Business Research Company that provides pulse oximeters market statistics, including pulse oximeters industry global market size, regional shares, competitors with a pulse oximeters market share, detailed pulse oximeters market segments, market trends and opportunities, and any further data you may need to thrive in the pulse oximeters industry. This pulse oximeters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pulse oximeter market size has grown steadily in recent years. It will grow from $2.64 billion in 2024 to $2.73 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to the increasing aging population, rise in respiratory diseases, hospital and healthcare infrastructure development, awareness and education, and global pandemic impact.
The pulse oximeter market size is expected to see strong growth in the next few years. It will grow to $3.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to integration with wearable devices, global health crises preparedness, government healthcare initiatives, health and wellness monitoring, and global health crises preparedness. Major trends in the forecast period include telehealth integration, technological advancements, home healthcare emphasis, smart features and connectivity, and remote patient monitoring in chronic diseases.
The forecast of 6.2% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher expenses for photodiode sensors and multi-wavelength light-emitting diode (LED) arrays, largely imported from China and Taiwan, affecting patient monitoring equipment availability.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of respiratory diseases is projected to drive growth in the pulse oximeter market in the future. Respiratory diseases are conditions affecting the airways and lungs, which impact human respiration. This increase is largely attributed to factors such as growing air pollution, dust exposure, an aging population, and smoking habits. Pulse oximeters are valuable in detecting changes in oxygen saturation levels before symptoms become noticeable. For example, in December 2023, the National Center for Biotechnology Information, a US-based government agency, reported that cases of COPD are expected to rise by 112 million, reaching a total of 592 million by 2050, representing 9.5% of the eligible population. Consequently, the growing prevalence of respiratory diseases is driving the demand for pulse oximeters.
The growing expansion of telehealth and telemedicine is expected to drive the growth of the pulse oximeter market in the future. Telehealth encompasses the use of telecommunications technology to deliver a variety of healthcare services and information remotely, while telemedicine specifically refers to remote clinical consultations and healthcare delivery. Pulse oximeters play a vital role in assessing oxygen levels from a distance, which is particularly important for at-home healthcare, especially for patients with chronic conditions. The integration of pulse oximeters with wearables and smartphones enhances their utility in telehealth, enabling seamless data sharing. This integration reduces the necessity for hospital visits, as patients can use pulse oximeters at home to transmit real-time data for remote evaluation. For instance, in June 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 30.1% of adults had used telemedicine in the past year. Therefore, the increasing expansion of telehealth and telemedicine is driving the growth of the pulse oximeter market.
Major companies in the pulse oximeter market are concentrating on developing technologically advanced solutions, such as cellular-connected pulse oximeters, to improve patient monitoring and data collection. A cellular-connected pulse oximeter is equipped with cellular connectivity features, enabling it to transmit data wirelessly over cellular networks (like 4G or 5G) to healthcare providers or cloud-based health platforms. For example, in August 2024, Prevounce Health LLC, a US-based developer of a remote monitoring platform, launched the Pylo OX1-LTE, a cellular-connected pulse oximeter specifically designed for remote patient monitoring (RPM). Aimed at patients with chronic respiratory conditions such as COPD and asthma, as well as those impacted by COVID-19, the device offers reliable cellular connectivity, accurate SpO2 and pulse rate readings, and a user-friendly design with a bright OLED screen. It integrates seamlessly with Prevounce's remote care management platform and can connect to third-party health software via the Pylo cloud API.
Prominent companies in the pulse oximeter market are actively investing in cutting-edge technologies, such as Pulse Oximetry (SpO2) Sensor Technology, to gain a competitive edge. Pulse Oximetry (SpO2) Sensor Technology employs specialized sensors to measure oxygen saturation levels in the blood, commonly expressed as SpO2. In November 2022, BioIntelliSense Inc., a US-based patient monitoring solutions company, introduced innovative pulse oximetry (SpO2) sensor technology addressing challenges related to skin pigmentation and motion monitoring. This patented sensor chipset and integrated processing technology ensure medical-grade accuracy, even across diverse skin tones and during movement. This breakthrough technology aims to contribute to healthcare equity by overcoming historical accuracy issues during activity and with darker skin tones. The design incorporates a unique white light emitter and spectral sensor, surpassing traditional architectures and providing clinically accurate SpO2 measurements.
In January 2022, ICU Medical, a US-based specialist in infusion therapy and critical care, completed the acquisition of Smiths Medical for an undisclosed amount. This strategic move enables ICU Medical to expand its product line with Smiths Medical's offerings, including infusion pumps, catheters, and various vascular access equipment. Smiths Medical, a US-based company specializing in innovative medical products, including pulse oximeters, adds valuable diversity to ICU Medical's portfolio through this acquisition.
Major companies operating in the pulse oximeter market include Medtronic Plc, GE Healthcare, Masimo Corporation, Nonin Medical Inc., Nihon Kohden Corporation, Koninklijke Philips NV, Philips Healthcare, Contec Medical Systems Co. Ltd., Omron Corporation, Carefusion Corp., CAS Medical Systems Inc., Opto Circuits India Ltd., Welch Allyn Inc., Spacelabs Healthcare, Meditech Equipment Co. Ltd., Vyaire Medical Inc., Beurer GmbH, Dragerwerk AG & Co. KGaA, ICU Medical Inc., Smiths Medical, Mindray Medical International Limited, Criticare Systems Inc., BPL Medical Technologies, ChoiceMMed America Co. Ltd., Beijing Choice Electronic Technology Co. Ltd., Creative Medical, Edan Instruments Inc., Heal Force Bio-Meditech Holdings Limited, Mediana Co. Ltd., Medlab Clinical Ltd.
North America was the largest region in the pulse oximeter market in 2024. The regions covered in the pulse oximeter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the pulse oximeter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pulse oximeter market consists of sales of finger-tip pulse oximeter, blood oxygen saturation monitor. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pulse Oximeter Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pulse oximeter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pulse oximeter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulse oximeter market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.